The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

Share Price Information for Creightons (CRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 23.00
Ask: 27.00
Change: 0.00 (0.00%)
Spread: 4.00 (17.391%)
Open: 25.00
High: 25.00
Low: 25.00
Prev. Close: 25.00
CRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Emma Hardie, Trading in own shares & TVR

27 Sep 2022 07:00

RNS Number : 7140A
Creightons PLC
27 September 2022
 

27 September 2022

 

CREIGHTONS plc ("Creightons" or the "Company")

Update on acquisition of Emma Hardie Limited

Trading in own shares and TVR

 

Creightons plc (LSE: CRL), manufacturers of personal care, beauty, and fragrance products, announces that further to the sale and purchase agreement ("SPA") relating to the acquisition of the entire share capital of Emma Hardie Limited as announced on 28 July 2021, the Company's subsidiary Potter and Moore Limited (P&M") has now made the final payment due to be made under the SPA to the sellers, and the Company and P&M has also entered into a settlement and share buyback agreement (the "Agreement") with the sellers in respect of certain matters related to the acquisition.

Final Payments to the Sellers under the SPA

The consideration for the transaction was approximately £6.36 million, comprising £5 million in cash and the issue of 1,600,000 ordinary shares of 1p each in the Company at the volume weighted average middle market CRL quoted price for the preceding 5 Business Days of 84.78p per share ("Consideration Shares"). Under the SPA, if on the date of twelve months from completion the volume weighted average middle market quoted price of an Ordinary Share for the last 5 Business days prior to that date (as derived from the Daily Official List of London Stock Exchange Plc) were to be less than £1.25, then an additional amount would be payable to the sellers in cash equal to such difference in price multiplied by the number of Consideration Shares issued. Having calculated the amounts due in accordance with the provisions of the SPA, the Company and each of the two sellers have now agreed the due amounts to be £666,832 per seller, being a total due amount of £1,333,664. P&M has made this payment to those sellers on 26 September 2022.

The additional payments due under the SPA comprising the adjustment payment and the deferred payment amounting in aggregate to £90,336 have also now been made to the sellers and no further amount is due to be paid by the Company or by P&M under the SPA.

Separate Share Buy Back of the Consideration Shares

Separately, it has been agreed with the two sellers that the Company buy back 800,000 Consideration Shares from each of them for a consideration of £288,000, being an aggregate consideration of£576,000 (together the "Buyback"). The consideration is based on the price of 36p per ordinary share being the on-market price at the time of the transaction. The Buyback took place on 26 September 2022.

The Company intends the total of 1,600,000 re-purchased shares to be held as treasury shares.

Accordingly, following the Buyback the Company's issued share capital now consists of 68,417,983 ordinary shares with voting rights (excluding treasury shares), with 1,600,000 ordinary shares held in treasury.

The above figure of 68,417,983 may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Mr Bernard Johnson Managing Director of the Company commented:

'We are pleased to announce the finalisation of the consideration for the acquisition of Emma Hardie Limited including the share buyback. Emma Hardie represents our first premium skincare brand and we remain confident that it will deliver significant return to shareholders in the years ahead.' 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a regulatory information service, this information is considered to be in the public domain.

Enquiries - Analysts and Investors:

Nicholas O'Shea, Director, Creightons Plc 01733 281000

Roland Cornish / Felicity Geidt, Beaumont Cornish Limited 0207 628 3396

Press Nigel Szembel, Anagallis Communications Limited 07802 362088

nigelszembel@anagallis.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSAALIRFIF
Date   Source Headline
21st Nov 20187:00 amRNSHalf-year Report
31st Oct 20187:00 amRNSInterim Results Presentation
19th Oct 20183:19 pmRNSEmployee Share Option Grant and PDMR dealings
1st Oct 201810:56 amRNSEmployee Share Options, Issue of Equity and TVR
10th Sep 20185:02 pmRNSExercise of Employee Share Options, TVR
30th Aug 20184:48 pmRNSResult of AGM
9th Aug 20185:41 pmRNSNotice of AGM and Dividend Declaration
26th Jul 20187:00 amRNSExercise of Options, Issue of Equity and TVR
26th Jun 20187:00 amRNSPreliminary Results
21st Jun 20182:49 pmRNSNotification of Preliminary Results for 2018
23rd Mar 201810:21 amRNSHolding(s) in Company
12th Feb 20184:40 pmRNSSecond Price Monitoring Extn
12th Feb 20184:35 pmRNSPrice Monitoring Extension
12th Feb 20183:33 pmRNSEmployee Share Options, Issue of Equity, TVR
8th Feb 20184:05 pmRNSTrading update - expected 2018 outturn
23rd Nov 201710:41 amRNSInterim Dividend Declaration
22nd Nov 20177:00 amRNSHalf-year Report
1st Nov 20173:14 pmRNSNotification of Interim Results for 2017
9th Oct 20173:34 pmRNSHolding(s) in Company
22nd Aug 201710:57 amRNSDirector/PDMR Shareholding
15th Aug 20177:00 amRNSExercise of Options, Issue of Equity, TVR
10th Aug 20173:06 pmRNSResult of AGM
28th Jun 20177:00 amRNSPreliminary Results for the year to 31 March 2017
19th Jun 20179:33 amRNSNotification of Preliminary Results for 2016
2nd Jun 20171:41 pmRNSHolding(s) in Company
6th Apr 20173:09 pmRNSHolding(s) in Company
16th Mar 20171:09 pmRNSDirector/PDMR Shareholding
27th Feb 201710:57 amRNSHolding(s) in Company
24th Feb 20176:17 pmRNSExercise of Share Options, PDMR Holdings, TVR
16th Feb 201711:11 amRNSHolding(s) in Company
15th Feb 20173:00 pmRNSHolding(s) in Company
23rd Nov 20162:49 pmRNSHalf-year Report
3rd Nov 20163:20 pmRNSNotice of Results and Trading update
21st Jul 20162:08 pmRNSResult of AGM
29th Jun 20169:19 amRNSAnnual Report and Notice of AGM
28th Jun 20168:15 amRNSFinal Results
23rd Feb 20167:00 amRNSHolding(s) in Company
23rd Feb 20167:00 amRNSHolding(s) in Company
16th Feb 20165:10 pmRNSAcquisition
18th Nov 20155:31 pmRNSDirector's Dealing
17th Nov 20155:33 pmRNSCorrection: Issue of Equity
16th Nov 20157:00 amRNSIssue of Equity
11th Nov 201511:30 amRNSHalf Yearly Report
10th Nov 20155:22 pmRNSHolding(s) in Company
20th Oct 20157:00 amRNSHolding(s) in Company
16th Sep 20152:16 pmRNSResult of AGM
10th Sep 20157:00 amRNSShare Option Grant
19th Jun 20157:00 amRNSFinal Results
18th Jun 20152:51 pmRNSAppointment of Auditors
29th May 20157:00 amRNSCompletion of Sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.